KIAA1199/CEMIP/HYBID overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma

Atsuhiro Koga; Norihiro Sato; Shiro Kohi; Kei Yabuki; Xiaobo Cheng; Masanori Hisaoka; Keiji Hirata

doi:10.1016/j.pan.2016.12.007

ScienceGate Book Chapters

JOURNAL ARTICLE

KIAA1199/CEMIP/HYBID overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma

Atsuhiro Koga Norihiro Sato Shiro Kohi Kei Yabuki Xiaobo Cheng Masanori Hisaoka Keiji Hirata

Year: 2016 Journal: Pancreatology Vol: 17 (1)Pages: 115-122 Publisher: Elsevier BV

DOI: 10.1016/j.pan.2016.12.007

Get Full-Text PDF Get Analytical Report

Keywords:

Gene knockdown Immunohistochemistry Medicine Cancer research Small interfering RNA Cell culture Pancreatic cancer Pancreatic ductal adenocarcinoma Oncology Internal medicine Cancer Biology Transfection

Metrics

Cited By

3.09

FWCI (Field Weighted Citation Impact)

Refs

0.92

Citation Normalized Percentile

Is in top 1%

Is in top 10%

Citation History

Topics

Proteoglycans and glycosaminoglycans research

Life Sciences → Biochemistry, Genetics and Molecular Biology → Cell Biology

Glycosylation and Glycoproteins Research

Life Sciences → Biochemistry, Genetics and Molecular Biology → Molecular Biology

Connective tissue disorders research

Life Sciences → Biochemistry, Genetics and Molecular Biology → Genetics

KIAA1199/CEMIP/HYBID overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma

Metrics

Citation History

Topics

Related Documents

Overexpression of KIAA1199 predicts poor prognosis in pancreatic cancer

DEK protein overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma

Decreased LKB1 predicts poor prognosis in Pancreatic Ductal Adenocarcinoma

HBXIP protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas

Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas